Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Larry Lesko

Premium

Lawrence Lesko, former director of the Office of Clinical Pharmacology at the US Food and Drug Administration’s Center for Drug Evaluation and Research, has joined MolecularHealth as a scientific advisor.

Lesko retired from his post at the FDA in June 2011 after nearly 20 years at the agency. He joined University of Florida's Medical City campus in Lake Nona last July as the director of the Center for Pharmacometrics and Systems Pharmacology.

Lesko will help the firm refine its drug safety assessment and prediction platform, called Molecular Analysis of Side Effects.

The FDA is in the process of evaluating MASE to figure out how it can use the software to predict drug safety issues in the post-market setting (PGx Reporter 2/15/2012).

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.